Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2008
08/28/2008US20080206222 Fullerenes; clathrates; side effect reduction
08/28/2008US20080206221 Nicotinamide Riboside Kinase Compositions and Methods for Using the Same
08/28/2008US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders
08/28/2008US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy
08/28/2008US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
08/28/2008US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy
08/28/2008US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine
08/28/2008US20080206203 Administering leukotriene antagonist such as pranlukast
08/28/2008US20080206201 Oncolytic myxovirus for targeting and destroying cancer cell; antitumor agents; tissue targeted therapy
08/28/2008US20080206199 Viral vector for target destruction of cancer cells
08/28/2008US20080206194 Inducing estrogen receptor-alpha expression by administering peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist
08/28/2008US20080206193 Angiogenesis inhibitors; immunomodulators; side effect reduction
08/28/2008US20080206192 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody (Alemtuzumab)
08/28/2008US20080206188 polyethylene glycol monomethyl ether or dimethyl ether, polyoxypropylene glycol; for an inflamed epithelium at risk of developing gut-derived sepsis from an intestinal pathogen; labeled package
08/28/2008US20080206187 thermal ablation; polyethylene oxide-polypropylene oxide copolymer sensitizes neoplastic cells to hyperthermia
08/28/2008US20080206159 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions
08/28/2008US20080206148 Imaging and destruction of malignant tumors using immunoimaging agents comprising nanoclusters incorporating monoclonal antibodies that selectively bind to the cell membrane of tumor cells; conjugates include an encapsulated near-infrared (NIR) fluorescing crystal; tissue-targeted treatment
08/28/2008US20080206139 Nanovesicles specifically targeted to abnormal cells; tissue-targeted therapy; central nervous system disorders such as astrocytoma; tumor-targeting therapy
08/28/2008DE102007008840A1 Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP) Novel polymorph of 2- (4-fluorophenyl) -4-3-hydroxy-3-methyl-1-butoxy) -5- [4-methylsulfonyl) phenyl] -3 (2H) -pyridazinone (FHMP)
08/28/2008DE102007008419A1 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 4- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives
08/28/2008CA2679602A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
08/28/2008CA2678755A1 Peptide vaccines for cancers expressing tumor-associated antigens
08/28/2008CA2678514A1 Chemical linkers with single amino acids and conjugates thereof
08/28/2008CA2678088A1 Combination therapy using tnf and alfa-galactosyl ceramide
08/28/2008CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
08/28/2008CA2675884A1 Quinoxaline compounds and use thereof
08/28/2008CA2672716A1 Novel therapeutic use for treating leukaemia
08/27/2008EP1962094A1 Detecting agent and therapeutic agent for highly malignant breast cancer
08/27/2008EP1961819A2 Composition and methods for the therapy and diagnosis of lung cancer
08/27/2008EP1961813A2 Human cyclin-dependent kinase (hPNQALRE)
08/27/2008EP1961811A1 Novel cytokine ZCYTOR17 ligand
08/27/2008EP1961767A2 Diagnosis and treatment of cancers and other conditions
08/27/2008EP1961761A1 Novel peptide compound
08/27/2008EP1961759A1 Integrin targeted cyclopeptide ligands, their preparation and use
08/27/2008EP1961428A1 SC6 antibody for treatment of cancer
08/27/2008EP1961418A1 The use of isothiocyanates compounds in treating prostatic diseases and skin cancer
08/27/2008EP1960778A2 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors
08/27/2008EP1960523A1 Modified pore-forming protein toxins and use thereof
08/27/2008EP1960434A2 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
08/27/2008EP1960403A1 Pyrrolotriazine kinase inhibitors
08/27/2008EP1960399A1 Pyrrolopyridines as kinase inhibitors
08/27/2008EP1960395A1 Plasminogen activator inhibitor-1 inhibitors
08/27/2008EP1960391A1 Piperazine derivatives and their use in therapy
08/27/2008EP1960380A1 F,g,h,i and k crystal forms of imatinib mesylate
08/27/2008EP1960375A1 Novel macrolide compounds with antibiotic and antneoplastic properties
08/27/2008EP1960372A1 Kinase inhibitors and their uses
08/27/2008EP1960371A1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase
08/27/2008EP1960370A1 Pyridiazinone derivatives for tumour treatment
08/27/2008EP1960368A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
08/27/2008EP1960365A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
08/27/2008EP1960361A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
08/27/2008EP1960358A1 Antineoplastic compounds
08/27/2008EP1959990A2 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/27/2008EP1959989A2 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/27/2008EP1959985A2 Use of prolactin in the prophylactic treatment of cancer
08/27/2008EP1959978A1 Compositions of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
08/27/2008EP1959964A1 Heteroaromatic sulfonamide prodrugs
08/27/2008EP1959958A1 Integrin-binding small molecules
08/27/2008EP1959957A1 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
08/27/2008EP1959955A2 Method of treating abnormal cell growth
08/27/2008EP1765776B1 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs)
08/27/2008EP1697318B1 Prolinylarylacetamides
08/27/2008EP1626974B1 Substituted benzopyrans as selective estrogen receptor-beta agonists
08/27/2008EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases
08/27/2008EP1603584B1 Aplidine for multiple myeloma treatment
08/27/2008EP1594886B1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates
08/27/2008EP1455781B1 Use of anastrozole for the treatment of post-menopausal women having early breast cancer
08/27/2008EP1406895B1 Lactone formulations and method of use
08/27/2008EP1384726B1 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
08/27/2008EP1359909B1 Triptolide prodrugs for anti-cancer therapy
08/27/2008EP1337560B1 Truncated cd200
08/27/2008EP1307188B1 Ajulemic acid for the treatment of cancer
08/27/2008EP1234025B1 Human enzymes of the metalloprotease family
08/27/2008EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease
08/27/2008EP1156817B1 Controlling protein levels in eucaryotic organisms
08/27/2008EP1115418B1 Diagnosis of cancers associated with viral infections using aglycoprotein 10B
08/27/2008EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1
08/27/2008EP0931157B1 Retroviral vectors
08/27/2008EP0649429B1 Heteroatomic oligonucleoside linkages
08/27/2008CN101253502A Drug, drug guidance system, magnetic detection system, and drug design method
08/27/2008CN101253274A Prostate stem cell markers
08/27/2008CN101253199A Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins
08/27/2008CN101253198A Antibody produced using ostrich and method for production thereof
08/27/2008CN101253192A Antitumor agent
08/27/2008CN101253180A 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
08/27/2008CN101253168A Substituted benzimidazoles as kinase inhibitors
08/27/2008CN101253154A Novel ansamycin derivatives
08/27/2008CN101252945A A pharmaceutical composition useful for the treatment of prostate cancer
08/27/2008CN101252934A Prokineticin 1 receptor
08/27/2008CN101252931A 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
08/27/2008CN101250547A Recombinant expression of human desmocyte growth factor-21
08/27/2008CN101250236A Tuckahoe dextran phosphate esterified derivative as well as preparation and use thereof
08/27/2008CN101250219A Short peptide series suppressing growth of leukemia cancer cell and uses thereof
08/27/2008CN101250212A 20(S) or 20(R)-dammarane-3 beta,12 beta, 20,25-tetraalcohol derivative, its salt and use thereof
08/27/2008CN101250189A Bisfatty amido substituted quinazolone derivatives as well as preparation method and use thereof as anti-cancer drugs
08/27/2008CN101250188A Technique for preparing willow leaf tabersonine
08/27/2008CN101250187A Fatty amido substituted methylindole quinoline derivatives as well as preparation method and use thereof as anti-tumour drugs
08/27/2008CN101250136A 1,3-diaryl-3-aryl amidine-1-acetoxime compounds, preparation method and use thereof
08/27/2008CN101250134A N-aryl-beta-aryl amidine-propionamide compounds, preparation method and use thereof
08/27/2008CN101250132A Polyfluoro ortho-hydroxybenzamide derivatives and uses thereof
1 ... 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 ... 2211